Literature DB >> 4975444

Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma.

S A Berson, R S Yalow.   

Abstract

The concentration of parathyroid hormone (measured by radioimmunoassay) in plasma of patients with severe chronic uremia is frequently much higher than it is in the majority of cases having adenomatous hyperparathyroidism. igher-than-normal concentrations of parathyroid hormone in plasma are found in a significant percentage of unselected patients with bronchogenic carcinoma.

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4975444     DOI： 10.1126/science.154.3751.907

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  55 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  [Surgical aspects of secondary hyperparathyroidism (author's transl)].

Authors:  H D Röher; R Wahl
Journal:  Langenbecks Arch Chir       Date:  1976-12-22

3.  Hypercalcemia and urinary excretion of cyclic AMP in bronchogenic carcinoma.

Authors:  G Francini; M Galli
Journal:  World J Surg       Date:  1977-07       Impact factor: 3.352

Review 4.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

5.  Carbohydrate metabolism and uraemia-mechanisms for glycogenolysis and gluconeogenesis.

Authors:  W H Hörl; J Stepinski; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

6.  Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.

Authors:  Peter Attia; Giao Q Phan; Paul H Duray; Steven A Rosenberg
Journal:  Am J Clin Oncol       Date:  2003-02       Impact factor: 2.339

7.  Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.

Authors:  D A Goldstein; L A Chui; S G Massry
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 8.  Metabolic bone disease secondary to renal and intestinal disorders.

Authors:  F P Muldowney
Journal:  Calif Med       Date:  1969-05

9.  Bone crystal maturation in renal osteodystrophy in humans.

Authors:  J M Burnell; E Teubner; J E Wergedal; D J Sherrard
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  The effects in the rat of varying intakes of dietary calcium, phosphorus, and hydrogen ion on hyperparathyroidism due to chronic renal failure.

Authors:  M Kaye
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.